Freestone Grove Partners LP Incyte Corp Call Options Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INCY
# of Institutions
706Shares Held
189MCall Options Held
909KPut Options Held
489K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.22 Billion23.54% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.54 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.6MShares$1.41 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1.08 Billion0.64% of portfolio
-
State Street Corp Boston, MA10MShares$723 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $16B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...